3-n-methylspiperone has been researched along with ketanserin in 5 studies
Studies (3-n-methylspiperone) | Trials (3-n-methylspiperone) | Recent Studies (post-2010) (3-n-methylspiperone) | Studies (ketanserin) | Trials (ketanserin) | Recent Studies (post-2010) (ketanserin) |
---|---|---|---|---|---|
155 | 6 | 7 | 3,094 | 335 | 283 |
Protein | Taxonomy | 3-n-methylspiperone (IC50) | ketanserin (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0021 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.265 | |
5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 6.5 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0184 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0027 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0016 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.29 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.015 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 1.8 | |
Synaptic vesicular amine transporter | Homo sapiens (human) | 0.18 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.001 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Billings, J; Kung, HF; Kung, MP; Murphy, RA | 1 |
Guo, YZ; Kasliwal, R; Kung, HF; Kung, MP; Mach, RH; Pan, SG | 1 |
Kristiansen, K; Kroeze, WK; Roth, BL; Shapiro, DA | 1 |
Chen, Z; Collier, T; Fu, H; Liang, SH; Rong, J; Zhou, J | 1 |
Inoue, O; Kobayasi, K; Suhara, T | 1 |
1 review(s) available for 3-n-methylspiperone and ketanserin
Article | Year |
---|---|
Positron Emission Tomography (PET) Imaging Tracers for Serotonin Receptors.
Topics: Brain; Humans; Ligands; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Serotonin | 2022 |
4 other study(ies) available for 3-n-methylspiperone and ketanserin
Article | Year |
---|---|
Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.
Topics: Animals; Benzofurans; Binding, Competitive; Chemical Phenomena; Chemistry; Corpus Striatum; Iodine Radioisotopes; Isotope Labeling; Male; Molecular Structure; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Tissue Distribution | 1990 |
Dopamine D-2 receptor imaging radiopharmaceuticals: synthesis, radiolabeling, and in vitro binding of (R)-(+)- and (S)-(-)-3-iodo-2-hydroxy-6-methoxy-N- [(1-ethyl-2-pyrrolidinyl)methyl]benzamide.
Topics: Animals; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; In Vitro Techniques; Iodine Radioisotopes; Male; Pyrrolidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
Topics: Amino Acid Substitution; Animals; Binding, Competitive; Conserved Sequence; COS Cells; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hydrolysis; Membrane Proteins; Models, Molecular; Mutagenesis, Site-Directed; Phosphatidylinositols; Protein Folding; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Signal Transduction; Tryptamines | 2000 |
Effect of desipramine on dopamine receptor binding in vivo.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzazepines; Cerebellum; Corpus Striatum; Desipramine; Dose-Response Relationship, Drug; In Vitro Techniques; Ketanserin; Male; Mice; Receptors, Dopamine; Spiperone | 1990 |